Plasma brain-derived tau (BD-Tau) as a biomarker in Alzheimer’s disease and acute neurological disorders

https://www.news-medical.net/whitepaper/20260220/Plasma-brain-derived-tau-(BD-Tau)-as-a-biomarker-in-Alzheimere28099s-disease-and-acute-neurological-disorders.aspx The identification and validation of biomarkers for neurodegenerative diseases - particularly Alzheimer’s disease (AD) - is advancing rapidly. These biomarkers play a critical role in enabling early diagnosis, tracking disease progression, and assessing how patients respond to treatment.